HIIFS
UTHR icon

Harel Insurance Investments & Financial Services’s United Therapeutics UTHR Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$157K Buy
+290
New +$163K ﹤0.01% 358
2023
Q4 		– Sell
-9,393
Closed -$2.12M – 690
2023
Q3 		$2.12M Sell
9,393
-658
-7% -$152K 0.04% 128
2023
Q2 		$2.22M Sell
10,051
-5,841
-37% -$1.29M 0.05% 94
2023
Q1 		$3.52M Sell
15,892
-540
-3% -$133K 0.07% 105
2022
Q4 		$4.55M Buy
16,432
+8,120
+98% +$2.05M 0.1% 92
2022
Q3 		$1.73M Buy
8,312
+3,272
+65% +$732K 0.04% 144
2022
Q2 		$1.19M Buy
+5,040
New +$1.02M 0.03% 170
2016
Q4 		– Sell
-141
Closed -$17K – 447
2016
Q3 		$17K Sell
141
-30
-18% -$3.6K ﹤0.01% 326
2016
Q2 		$18K Sell
171
-40
-19% -$4.46K ﹤0.01% 474
2016
Q1 		$24K Sell
211
-50
-19% -$6.33K ﹤0.01% 261
2015
Q4 		$41K Buy
+261
New +$38K ﹤0.01% 210

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Harel Insurance Investments & Financial Services's UTHR Position: Q2 2026 in Review

Harel Insurance Investments & Financial Services opened a new position in United Therapeutics (UTHR) in Q2 2026: 290 shares worth $157K. The stake represents ﹤0.01% of the portfolio and ranks #358 among its holdings. This is a return to the name: Harel Insurance Investments & Financial Services previously reported a position in UTHR as recently as Q3 2023.

Harel Insurance Investments & Financial Services first reported a position in UTHR in Q4 2015 and has held it in 11 quarters since. The position peaked at $4.55M in Q4 2022. 417 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Harel Insurance Investments & Financial Services held 290 shares of United Therapeutics worth $157K as of Q2 2026.
  • United Therapeutics was a new Harel Insurance Investments & Financial Services position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Harel Insurance Investments & Financial Services's portfolio in Q2 2026, its #358 holding.
  • Harel Insurance Investments & Financial Services first reported a position in United Therapeutics in Q4 2015 and has held it in 11 quarters since.
  • Harel Insurance Investments & Financial Services's United Therapeutics position peaked at $4.55M in Q4 2022.
  • 417 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.